| Ytd | -87.29% | |
| 1y | -99.34% |
| Open | 2.20 | Prev Close | 2.20 | Low | 2.19 | High | 2.33 | Mkt Cap | 3.42M |
| Vol | 176.44K | Avg Vol | 2.21M | EPS | -175.92 | P/E | N/A | Forward P/E | N/A |
| Beta | -1.51 | Short Ratio | 1.88 | Inst. Own | 16.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.29 | 200-d Avg | 95.33 | 1yr Est | 0.00 |
CMND News
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
Vancouver, Canada, June 29, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearm
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
The patent, which refers to Clearmind's molecule MEAI (5-methoxy-2-aminoindane), covers innovati
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
Taylor Morrison Home soared 23.28% to $72.12 in pre-market trading after Berkshire Hathaway announce
This advancement strengthens Clearmind's robust intellectual property portfolio, which already
The approval advances the multicenter study titled "A Phase I/II Single and Multiple Dose Tolera
US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-st
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
The European patent application forms part of the Company's exclusive worldwide licensing agreem
Positive clinical results from Alcohol Use Disorder clinical trial may strengthen potential for elig
Clearmind Medicine Inc. (NYSE: CMND) faces a price correction Wednesday following a massive rally. R
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial
US stocks up as Dow Jones gains 0.48% and NASDAQ rises 0.03%. Retail sales up 1.7% in March, while p
US stocks down at midday, Dow down 0.2%, NASDAQ down 0.52%. Energy up 1.1%, consumer discretionary d
US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric
Clearmind Medicine shares are trading higher Monday after CMND-100 meets the primary endpoint in its
MRVL: 7% | Google Teams Up With Marvell Technology To Build New AI Chips, Invests Heavily In TPU Str
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
The positive DSMB recommendation follows the successful completion of the third cohort and is based
Dow Jones up 200 points, consumer discretionary shares rise 1.8%, Wells Fargo reports worse-than-exp
US stocks rise, Nasdaq up 200 points. Dow up 0.03%, S&P 500 up 0.35%. Consumer discretionary sha
Company completed treatment in four additional participate at its Israel clinical siteVancouver, Can
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-sta